• Privacy policy
  • T&C’s
  • About Us
    • FAQ
    • Meet the Team
  • Contact us
TLE ONLINE SHOP!
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
  • TLE
  • News
  • Politics
  • Business
  • Sport
  • Opinion
  • Elevenses
  • Entertainment
    • All Entertainment
    • Film
    • Lifestyle
      • Horoscopes
    • Lottery Results
      • Lotto
      • Thunderball
      • Set For Life
      • EuroMillions
  • Food
    • All Food
    • Recipes
  • Property
  • Travel
  • Tech/Auto
No Result
View All Result
The London Economic
No Result
View All Result
Home Business and Economics Business

PhD boffin set to be one of richest men in Britain after his company is sold for £625million

Harry Destecroix, 31, set up Ziylo while studying for his doctorate - and the firm could revolutionise the treatment of diabetes

Joe Mellor by Joe Mellor
2018-08-21 11:14
in Business, News
FacebookTwitterLinkedinEmailWhatsapp

Brainy Harry Destecroix, 31, set up Ziylo while studying for his doctorate – and the firm could revolutionise the treatment of diabetes.

The PhD scientist and other shareholders could become some of the richest men in Britain after his company started at university was sold – for around £625 MILLION.

Novo Nordisk, the world’s biggest maker of diabetes drugs, has agreed to buy Ziylo to develop new forms of insulin.

Total payments under the agreement could ultimately exceed $800m (£624m) upon the achievement of development, regulatory and sales milestones by Novo Nordisk.

Ziylo has developed synthetic molecules which bind to glucose in the bloodstream to help diabetics control their condition.

It eliminates the risk of low blood sugar which can lead to death in severest cases.

RelatedPosts

Syrian doctor uses annual leave to treat Ukraine war victims – after he came to UK as refugee

Watch: Trashion show? Activist wears all his own rubbish for an entire month

Watch: Parody of MPs ‘defence’ of PM’s latest party pic is going viral

PM braced for criticism as Sue Gray report finally published while Mirror have ANOTHER party pic

Scientists at the university’s Davis Research Group, including professor Anthony Davis, worked on the problem for many years before Ziylo was established in 2014.

The firm was spun out of the University of Bristol, where Destecroix earned his doctorate in chemistry four years ago.

Harry Destecroix  around the time co-founded Ziylo with Prof Anthony Davis, of the University of Bristol and Tom Smart.

The glucose-binding molecules were designed by Bristol professor Anthony Davis.

Dr Harry Destecroix said: “Novo Nordisk, as the leader in the diabetes field, is the ideal company to maximise the potential of the Ziylo’s glucose binding molecules in glucose responsive insulins and diabetes applications, and it brings hope of a truly ground-breaking treatment to diabetes patients.”

Anthony Davis, Professor of Supramolecular Chemistry at the University of Bristol and Director & Co-Founder of Ziylo, added: “The glucose responsive insulin we will develop with Novo Nordisk combines a natural molecule (insulin) with an artificial component (Ziylo’s glucose binding molecules). This combination of natural and unnatural could be a new approach to biodesign.”

Ziylo has received just £2m in funding since its formation, from individual angel investors and government grants.

Mr Destecroix said Novo Nordisk could start clinical trials of products based on Ziylo technology within three years.

The research and development work will take place in Novo Nordisk’s new £115m diabetes research centre in Oxford, which will be inaugurated next month, as well as at its facilities in Denmark.

Professor Nishan Canagarajah, Pro Vice-Chancellor for Research at the University of Bristol, said: “The university is proud of its cutting-edge research which has potential to generate major societal impact. It is gratifying to see our research being developed to the point where it has the potential to make a real difference to people’s lives.

“The acquisition of Ziylo by Novo Nordisk will allow this technology to take the next leap forward – well done to the team at Ziylo and to Professor Davis and his team at the University for getting to this exciting point.”

Since you are here

Since you are here, we wanted to ask for your help.

Journalism in Britain is under threat. The government is becoming increasingly authoritarian and our media is run by a handful of billionaires, most of whom reside overseas and all of them have strong political allegiances and financial motivations.

Our mission is to hold the powerful to account. It is vital that free media is allowed to exist to expose hypocrisy, corruption, wrongdoing and abuse of power. But we can't do it without you.

If you can afford to contribute a small donation to the site it will help us to continue our work in the best interests of the public. We only ask you to donate what you can afford, with an option to cancel your subscription at any point.

To donate or subscribe to The London Economic, click here.

The TLE shop is also now open, with all profits going to supporting our work.

The shop can be found here.

You can also SUBSCRIBE TO OUR NEWSLETTER .

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

Trending on TLE

  • All
  • trending
Abdollah

‘Rescue us’: Afghan teacher begs UK to help him escape Taliban

CHOMSKY: “If Corbyn had been elected, Britain would be pursuing a much more sane course”

What If We Got Rid Of Prisons?

More from TLE

Considerations For Going Global

Set For Life Results for Monday 28 February 2022 Tonight’s winning numbers

Trendy Shoreditch hotel opens up bedroom that resembles a womb to combat “first night effect”

Landmark court case considers whether to decriminalise street prostitution

400-year-old Shark’s first question was “Does Kronenbourg still taste like piss?”

5 years on: EU official says UK ‘isolated and weakened by Brexit aberration’

Contempt of parliament? This government is in contempt of its people

‘Levelling up is a lie’: Boris set to scrap High Speed 3

Legends and Leaders, or Satans and Spinners

Coronavirus UK – Wetherspoons’ ex-smoker boss would take his chances with coronavirus

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.




No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Meet the Team
    • Privacy policy
  • Contact us

© 2019 thelondoneconomic.com - TLE, International House, 24 Holborn Viaduct, London EC1A 2BN. All Rights Reserved.